Poster Abstract Session:
123. Stewardship: Improving Treatments
Friday, October 4, 2013: 12:30 PM-2:00 PM
Room: The Moscone Center: Poster Hall C


Presentations:

Broad-spectrum antibiotics offer no advantage over guideline-recommended antibiotics for patients with severe community-acquired pneumonia (CAP)
Kate Kupiec, PharmD ; James Johnson, PharmD ; Christopher Ohl, MD ; James Beardsley, PharmD ; Vera Luther, MD ; John Williamson, PharmD

Ciprofloxacin Automatic Stop on Pneumonia Pathway Orders  - Impact on Clinical Outcomes
Lisa Avery, PharmD, BCPS ; Rebecca Wedow, Pharm.D. ; Cynthia Wong, M.D. ; Ashley Woodruff, Pharm.D, BCPS ; Jill Lavigne, PhD, MPH

Antibiotic Prescribing Practices among Patients Hospitalized with Acute Bacterial Skin and Skin Structure Infection:  Results of a Multi-Center Study
Timothy Jenkins, MD ; Brooke Caldwell, MD ; Bruce Mccollister, MD ; S. Jason Moore, PhD, PA ; Sean O'leary, MD, MPH ; Sean Pawlowski, MD ; Daniel Perlman, MD ; Carla Saveli, MD ; Bryan Knepper, MPH, MSc ; William Burman, MD

The Impact of Ertapenem Use on Resistance Trends within an Eleven Hospital System
Caitlin Handler, PharmD ; Andrea Stock, PharmD ; S. Christian Cheatham, PharmD

Clinical Impact of De-escalation to Ertapenem (ETP) in Enterobacteriaceae (EB) infections in Intensive Care Units (ICUs) from Seven Hospitals in Colombia
Victor M Blanco, MD ; Marta Vallejo, MD ; Cristhian Hernandez, Bsc ; Diana Cuesta, MD, PhD ; Juan J Maya, MD ; Gabriel Motoa, MD ; Adriana Correa, MSc ; John Quinn, MD ; Maria V. Villegas, MD, MSc

Piperacillin/tazobactam- and Cefepime-Based Therapy in Hospitalized Patients and the Risk of Subsequent Isolation of Multidrug-Resistant Organisms (MDRO)
Krystina Woods, MD ; Tomasz Jodlowski, PharmD, BCPS ; Manuel Revuelta, MD ; Donna Mildvan, MD ; David C. Perlman, MD ; Jorg Ruhe, MD MPH
Posters
  • WoodsIDW2013.pdf (414.1 kB)

  • New territory for antimicrobial stewards: weight based dosing in the obesity era
    Jennifer Goldman, MD ; Leslie Stach, PharmD, BCPS ; Mary Anne Jackson, MD, FIDSA

    Effect of Piperacillin/tazobactam Restriction on Prescribing Habits and Rates of Acute Renal Failure
    Michael A. Lorenz, Pharm.D. ; Ryan P. Moenster, Pharm.D. ; Travis W. Linneman, Pharm.D.

    Antibiotic (ABX) De-escalation in Sepsis: A Retrospective Study in a Tertiary Care Medical Center with an Established Antimicrobial Stewardship Program (ASP)
    Shara Ann Betito, MD ; Christopher Ohl, MD ; John Williamson, PharmD ; James Johnson, PharmD ; James Beardsley, PharmD ; Vera Luther, MD
    Posters
  • Betito IDSA Poster FINAL-1.pdf (702.2 kB)

  • Antimicrobial use associated with the implementation of fever and neutropenia clinical practice guidelines in cancer patients
    Jessica Gillon, PharmD ; Adam Esbenshade, MD ; Debra Friedman, MD ; M. Cecilia Di Pentima, MD, MPH

    Compliance of Antibiotic Intraoperative REdosing: The CARE Study
    Gina Riggi, PharmD ; Mayela Castillo, PharmD, BCPS ; Margaret Fernandez, PharmD, BCPS ; Andrew Wawrzyniak, PhD ; Michael Vigoda, MD ; Lilian Abbo, MD

    Outpatient Antimicrobial Consumption and Frequency of Resistance in Suwa area, Nagano, Japan
    Yoshiaki Gu, MD, MPH ; Etsuji Okamoto, MD, MPH ; Hajime Kanamori, MD, PhD, MPH ; Shiro Endo, MD, PhD ; Tetsuji Aoyagi, MD, PhD ; Masumitsu Hatta, MD, PhD ; Koichi Tokuda, MD, PhD, MPH ; Hisakazu Yano, MD, PhD ; Mitsuo Kaku, MD, PhD

    Antibiotic Use in Patients Hospitalized for Community-acquired Pneumonia (CAP)
    Daniel Musher, MD, FIDSA ; Zeeshan Afzal, MD ; Nancy Logan ; Charles Stager, PhD

    Analysis of Seizure Activity with Cefepime Use in a Large Metropolitan Teaching Hospital
    Rachel Staudt, PharmD ; Gina Caliendo, PharmD, BCPS ; Victoria Adams, PharmD, BCPS ; Patricia Saunders-Hao, PharmD, BCPS

    Implementation of a Guideline for Community-Acquired Pneumonia is Associated with a Reduction in Antibiotic Class Switching and Length of Therapy
    Michelle Haas, MD ; Bryan Knepper, MPH, MSc ; Sarah Stella, MD ; Lilia Cervantes, MD ; Connie Price, MD ; William Burman, MD ; Philip Mehler, MD ; Timothy Jenkins, MD

    Identification of Clinical Factors for Performing Voriconazole (VRC) Therapeutic Drug Monitoring (TDM) at an Academic Medical Center
    Mildred Vicente, PharmD ; Jennifer Pisano, MD ; Sandeep Parsad, PharmD ; Natasha Pettit, PharmD ; Kenneth Pursell, MD ; Benjamin Brielmaier, PharmD

    Validation of a Current Severe Sepsis Antibiotic Treatment Algorithm: Identifying Areas for Further Refinement
    Elizabeth S. Zhu, Pharm.D., BCPS ; Cinda Christensen, Pharm.D., BCPS-ID ; Hien H. Nguyen, MD, MAS

    Management of Staphylococcus aureus Bacteremia: Room for Improvement
    Rossana Rosa, MD ; Andrew Wawrzyniak, PhD ; Maroun Sfeir, M.D. ; Laura Smith, Pharm.D ; Lilian Abbo, MD

    Lean Body Mass Index is a Risk Factor for Linezolid Induced Thrombocytopenia
    Bunki Natsumoto, MD ; Kyoko Yokota, MD ; Fumio Omata, MD, MPH ; Keiichi Furukawa, MD
    Posters
  • IDSA.9.28PDF.pdf (674.5 kB)

  • How do Regional Differences in Antibiotic Consumption Correlate with the Number of Trade Names in a Market?
    Carmina Mancenon, Operations Research and Financial Engineering Student at Princeton University
    Posters
  • POSTERPRINCETON[NB].pdf (667.3 kB)

  • Use of Educational Strategies to Reduce Inappropriate Antibiotic Consumption: Experience in an Academic Tertiary-Care Center in Mexico
    María Eugenia Pérez Aguinaga, MD ; Marisol Manríquez Reyes, MD ; Carlos Agudelo Restrepo, MD, MSc ; Alethse De la Torre Rosas, MD ; Ma. De Lourdes Guerrero Almeida, MD, MSc ; Elia Criollo Mora, PhC ; Alejandro Macías Hernández, MD MS ; Arturo Galindo Fraga, MD MSc ; Guillermo Ruiz Palacios, MD PhD
    Posters
  • POST STEWARDSHIP IDW13.pdf (1.3 MB)

  • Barriers in Removing Penicillin Allergy Documentation on Hospital Readmissions
    Ramzy Rimawi, MD ; Paul Cook, MD ; Bassam Rimawi, MD ; Dawd Siraj, MD, MPH ; Muhammad Salman Ashraf, MD ; Kaushal Shah, M.D.
    Posters
  • Slide1.jpg (124.7 kB)
  • CME Credits:

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.